Century Therapeutics (IPSC) Earnings Date & Reports

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IPSC is expected to report earnings to fall 142.70% to -37 cents per share on August 07

Century Therapeutics IPSC Stock Earnings Reports

Q2'25

Est.

$-0.38

Q1'25

Beat

by $0.96

Q4'24

Est.

$-0.41

Q3'24

Beat

by $0.08

Q2'24

Beat

by $0.07

The last earnings report on May 16 showed earnings per share of 88 cents, beating the estimate of -7 cents. With 6.19M shares outstanding, the current market capitalization sits at 46.09M.

View a ticker or compare two or three

Compare

IPSC